Literature DB >> 30735286

Structural signature of sporadic Creutzfeldt-Jakob disease.

J Navid1, G S Day1,2, J Strain1, R J Perrin2,3,4, R C Bucelli1, A Dincer5, J K Wisch1, D Soleimani-Meigooni6, J C Morris1,2,3,4, T L S Benzinger2,5, B M Ances1,2,4,5.   

Abstract

BACKGROUND AND
PURPOSE: Sporadic Creutzfeldt-Jakob disease (sCJD) is a rapidly progressive neurodegenerative disease caused by an abnormal isoform of the human prion protein. Structural magnetic resonance imaging in patients with pathologically confirmed sCJD was compared with cognitively normal individuals to identify a cortical thickness signature of sCJD.
METHODS: This retrospective cross-sectional study compared patients with autopsy-confirmed sCJD with dementia (n = 11) with age- and sex-matched cognitively normal individuals (n = 22). We identified regions of interest (ROIs) in which cortical thickness was most affected by sCJD. Within patients with sCJD, the relationship between ROI cortical thickness and clinical measures (disease duration, cerebrospinal fluid tau and diffusion-weighted imaging abnormalities) was evaluated.
RESULTS: Compared with cognitively normal individuals, patients with sCJD had significantly reduced cortical thickness in multiple ROIs, including the fusiform gyrus, precentral gyrus, precuneus and superior temporal gyrus bilaterally; the caudal middle frontal gyrus, superior frontal gyrus, postcentral gyrus, inferior temporal gyrus and transverse temporal gyrus in the left hemisphere; and the superior parietal lobule in the right hemisphere. Only one patient with sCJD had co-pathology consistent with Alzheimer's disease. Reduced cortical thickness did not correlate with disease duration, presence of diffusion restriction or elevated cerebrospinal fluid tau.
CONCLUSION: Cortical signature changes in sCJD may reflect brain changes not captured by standard clinical measures. This information may be used with clinical measures to inform the progression of sCJD and patterns of prion protein spread throughout the brain. These results may have implications for prediction of symptomatic progression and plausibly for development of therapeutic strategies.
© 2019 EAN.

Entities:  

Keywords:  Creutzfeldt-Jakob disease; biomarker; cortical signature; cortical thickness; magnetic resonance imaging; neurodegenerative disorders; prion diseases; rapidly progressive dementia

Mesh:

Substances:

Year:  2019        PMID: 30735286      PMCID: PMC6615963          DOI: 10.1111/ene.13930

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  28 in total

1.  First symptom in sporadic Creutzfeldt-Jakob disease.

Authors:  G D Rabinovici; P N Wang; J Levin; L Cook; M Pravdin; J Davis; S J DeArmond; N M Barbaro; J Martindale; B L Miller; M D Geschwind
Journal:  Neurology       Date:  2006-01-24       Impact factor: 9.910

2.  Classification of sporadic Creutzfeldt-Jakob disease revisited.

Authors:  Ignazio Cali; Rudolph Castellani; Jue Yuan; Amer Al-Shekhlee; Mark L Cohen; Xiangzhu Xiao; Francisco J Moleres; Piero Parchi; Wen-Quan Zou; Pierluigi Gambetti
Journal:  Brain       Date:  2006-09       Impact factor: 13.501

3.  An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest.

Authors:  Rahul S Desikan; Florent Ségonne; Bruce Fischl; Brian T Quinn; Bradford C Dickerson; Deborah Blacker; Randy L Buckner; Anders M Dale; R Paul Maguire; Bradley T Hyman; Marilyn S Albert; Ronald J Killiany
Journal:  Neuroimage       Date:  2006-03-10       Impact factor: 6.556

Review 4.  Cellular biology of prion diseases.

Authors:  D A Harris
Journal:  Clin Microbiol Rev       Date:  1999-07       Impact factor: 26.132

5.  Diffusion-weighted and fluid-attenuated inversion recovery imaging in Creutzfeldt-Jakob disease: high sensitivity and specificity for diagnosis.

Authors:  Geoffrey S Young; Michael D Geschwind; Nancy J Fischbein; Jennifer L Martindale; Roland G Henry; Songling Liu; Ying Lu; Stephen Wong; Hong Liu; Bruce L Miller; William P Dillon
Journal:  AJNR Am J Neuroradiol       Date:  2005 Jun-Jul       Impact factor: 3.825

6.  Measuring the thickness of the human cerebral cortex from magnetic resonance images.

Authors:  B Fischl; A M Dale
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-26       Impact factor: 11.205

7.  Magnetic resonance imaging in the clinical diagnosis of Creutzfeldt-Jakob disease.

Authors:  A Schröter; I Zerr; K Henkel; H J Tschampa; M Finkenstaedt; S Poser
Journal:  Arch Neurol       Date:  2000-12

8.  Molecular classification of sporadic Creutzfeldt-Jakob disease.

Authors:  Andrew F Hill; Susan Joiner; Jonathan D F Wadsworth; Katie C L Sidle; Jeanne E Bell; Herbert Budka; James W Ironside; John Collinge
Journal:  Brain       Date:  2003-06       Impact factor: 13.501

9.  Differential diagnosis of 201 possible Creutzfeldt-Jakob disease patients.

Authors:  Bart Van Everbroeck; Itte Dobbeleir; Michele De Waele; Peter De Deyn; Jean-Jacques Martin; Patrick Cras
Journal:  J Neurol       Date:  2004-03       Impact factor: 4.849

Review 10.  Sporadic and familial CJD: classification and characterisation.

Authors:  Pierluigi Gambetti; Qingzhong Kong; Wenquan Zou; Piero Parchi; Shu G Chen
Journal:  Br Med Bull       Date:  2003       Impact factor: 4.291

View more
  1 in total

1.  Selective vulnerability to atrophy in sporadic Creutzfeldt-Jakob disease.

Authors:  Kyan Younes; Julio C Rojas; Amy Wolf; Goh M Sheng-Yang; Matteo Paoletti; Gianina Toller; Eduardo Caverzasi; Maria Luisa Mandelli; Ignacio Illán-Gala; Joel H Kramer; Yann Cobigo; Bruce L Miller; Howard J Rosen; Michael D Geschwind
Journal:  Ann Clin Transl Neurol       Date:  2021-05-05       Impact factor: 4.511

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.